Table 2.
Targeted high-risk medications, depending on subtype of heart failure
| Heart Failure (any subtype) | Heart Failure With Reduced Ejection Fraction |
|---|---|
| Oral nonsteroidal antiinflammatory drugs | Cilostazol |
| Dipeptidyl peptidase-4 inhibitors | High-risk antiarrhythmics |
| Alogliptin | Disopyramide |
| Saxagliptin | Dronedarone |
| Thiazolidinediones | Flecainide |
| Pioglitazone | Propafenone |
| Rosiglitazone | Select calcium channel blockers |
| Diltiazem | |
| Verapamil | |
| Nifedipine |